Discussion
Immunosuppressive treatment for Sjögren’s disease-associated interstitial lung disease (ILD) has become more common in recent years, particularly among patients with greater respiratory symptoms or poorer lung function, a European study found. Despite the shift toward more frequent and diverse treatment, the proportion of patients whose lung disease worsened after…